Literature DB >> 28653886

The miR-608 rs4919510 polymorphism may modify cancer susceptibility based on type.

Shuangshuang Wu1, Weiyan Yuan2, Yu Shen1, Xiao Lu3, Yue Li1, Tian Tian4, Liying Jiang4, Xun Zhuang4, Jianqing Wu1, Minjie Chu4.   

Abstract

Previous meta-analysis has not shown different effects of miR-608 rs4919510 polymorphism in specific cancer types and reported no significant association between rs4919510 and cancer risk among Chinese. However, more recent findings have been inconsistent. Therefore, we performed an updated meta-analysis to examine whether this polymorphism is associated with cancer risk based on ethnicity and type. A total of 18 case-control studies, comprising 12,517 cases and 15,624 controls, were included in our study. Surprisingly, in contrast with previous meta-analysis, a significant association between the rs4919510 polymorphism and cancer risk was observed in Chinese (CG vs CC: odds ratio = 1.11; 95% confidence interval = 1.04-1.19). In further stratified analyses based on cancer type, rs4919510 was significantly associated with an increased risk of papillary thyroid cancer (CG vs CC: odds ratio = 1.25; 95% confidence interval = 1.01-1.54) and exhibited borderline significant associations with increased risk of gastric cancer (GG vs CC: odds ratio = 1.27; 95% confidence interval = 1.00-1.62) and lung cancer (CG vs CC: odds ratio = 1.14; 95% confidence interval = 0.99-1.32), but a decreased risk of colorectal cancer (GG vs CC: odds ratio = 0.74; 95% confidence interval = 0.60-0.91). Moreover, the RegulomeDB database indicated that rs4919510 may affect the expression of two nearby genes ( SEMA4G and MRPL43), and the Cancer Genome Atlas database revealed that the expression level of SEMA4G was significantly lower in colorectal cancer and lung cancer tissues than that in adjacent non-tumour tissues, while the expression level of SEMA4G was significantly higher in gastric cancer tissues than that in adjacent non-tumour tissues. These findings provide evidence that the miR-608 rs4919510 polymorphism may modify cancer susceptibility in a type-specific manner. Furthermore, SEMA4G may function as an oncogene or tumour suppressor to regulate tumour development in a type-specific manner. Further studies with experimental evaluations are warranted.

Entities:  

Keywords:  MiR-608; cancer; polymorphism; rs4919510; the Cancer Genome Atlas

Mesh:

Substances:

Year:  2017        PMID: 28653886     DOI: 10.1177/1010428317703819

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  9 in total

1.  PROL1 is essential for xenograft tumor development in mice injected with the human prostate cancer cell-line, LNCaP, and modulates cell migration and invasion.

Authors:  Amarnath Mukherjee; Augene Park; Kelvin Paul Davies
Journal:  J Mens Health       Date:  2021-10-14       Impact factor: 0.789

2.  Genetic polymorphisms and gastric cancer risk: a comprehensive review synopsis from meta-analysis and genome-wide association studies.

Authors:  Jie Tian; Guanchu Liu; Chunjian Zuo; Caiyang Liu; Wanlun He; Huanwen Chen
Journal:  Cancer Biol Med       Date:  2019-05       Impact factor: 5.347

3.  MicroRNA‑608 sensitizes non‑small cell lung cancer cells to cisplatin by targeting TEAD2.

Authors:  Yanli Wang; Fengcai Li; Dandan Ma; Yuhua Gao; Runpu Li; Yingjie Gao
Journal:  Mol Med Rep       Date:  2019-08-26       Impact factor: 2.952

Review 4.  Abnormal Expression of Mitochondrial Ribosomal Proteins and Their Encoding Genes with Cell Apoptosis and Diseases.

Authors:  Guomin Huang; Hongyan Li; Hong Zhang
Journal:  Int J Mol Sci       Date:  2020-11-23       Impact factor: 5.923

Review 5.  MicroRNAs: Emerging players in the pathogenesis of vitiligo.

Authors:  Xin Yu; Yuli Cui; Xueqing Zhu; Hongjun Xu; Linfeng Li; Guangcheng Gao
Journal:  Front Cell Dev Biol       Date:  2022-09-16

6.  No Association Between MicroRNA-608 rs4919510 G>C Polymorphism and Digestive System Cancers Susceptibility: A Meta-Analysis Based on 10,836 Individuals.

Authors:  Xue-Feng Li; Ju-Kun Song; Jun-Wei Cai; Yu-Qin Zeng; Min Li; Jie Zhu; Yu-Ming Niu
Journal:  Front Physiol       Date:  2018-06-07       Impact factor: 4.566

7.  The role of microRNA-608 polymorphism on the susceptibility and survival of cancer: a meta-analysis.

Authors:  Zhi-Ming Dai; Jian-Rui Lv; Kang Liu; Xiao-Ming Lei; Wei Li; Gang Wu; Xing-Han Liu; Yu-Xiao Zhu; Qian Hao; Zhi-Jun Dai
Journal:  Aging (Albany NY)       Date:  2018-06-16       Impact factor: 5.682

8.  Nonconserved miR-608 suppresses prostate cancer progression through RAC2/PAK4/LIMK1 and BCL2L1/caspase-3 pathways by targeting the 3'-UTRs of RAC2/BCL2L1 and the coding region of PAK4.

Authors:  Xu Zhang; Jiajie Fang; Shiming Chen; Weiyu Wang; Shuai Meng; Ben Liu
Journal:  Cancer Med       Date:  2019-08-07       Impact factor: 4.452

Review 9.  Single Nucleotide Polymorphisms in microRNA Genes and Colorectal Cancer Risk and Prognosis.

Authors:  Maria Radanova; Mariya Levkova; Galya Mihaylova; Rostislav Manev; Margarita Maneva; Rossen Hadgiev; Nikolay Conev; Ivan Donev
Journal:  Biomedicines       Date:  2022-01-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.